Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes

Blood

Volumn 113, Issue 7, 2009, Pages 1543-1546

  Diamandis, Maria ^a   Paterson, Andrew D ^b,c   Rommens, Johanna M ^b,c   Veljkovic, D Kika ^a   Blavignac, Jessica ^a   Bulman, Dennis E ^d   Waye, John S ^a   Derome, Francine ^e   Rivard, Georges E ^e   Hayward, Catherine P M ^a,f  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; MESSENGER RNA; UROKINASE;

ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL DIFFERENTIATION; CHROMOSOME 10Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC MARKER; HUMAN; HYPOTHESIS; LINKAGE ANALYSIS; MEGAKARYOCYTE; MULTIPOTENT STEM CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; QUEBEC PLATELET DISORDER; SOUTHERN BLOTTING; THROMBOCYTE DYSFUNCTION;

EID: 61849180824     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-175216     Document Type: Article

References (22)

1. Dahlback B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med. 2005;257:209-223.
2. Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CP. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis. 2008;19:109-119.
3. Othman M, Notley C, Lavender FL, et al. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood. 2005;105:4330-4336.
4. McKay H, Derome F, Haq MA, et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood. 2004;104:159-165.
5. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood. 2001; 98:257-265.
6. Diamandis M, Veljkovic DK, Derome F, Rivard GE, Hayward CP. Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder. Blood Coagul Fibrinolysis. 2008;19:463-464.
7. Veljkovic DK, Rivard GE, Diamandis M, et al. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation. Blood. 2009;113: 1535-1542.
8. Kufrin D, Eslin DE, Bdeir K, et al. Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets. Blood. 2003;102:926-933.
9. Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood. 2008;111:981-986.
10. Gnatenko DV, Dunn JJ, McCorkle SR, et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood. 2003;101:2285-2293.
11. Johnsen JM, Levy GG, Westrick RJ, Tucker PK, Ginsburg D. The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele. Mamm Genome. 2008;19:32-40.
12. Nagamine Y, Medcalf RL, Munoz-Canoves P. Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb Haemost. 2005;93:661-675.
13. Cai J, Goodman BK, Patel AS, et al. Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet. 2003;114:68-76.
14. de Kok YJ, Vossenaar ER, Cremers CW, et al. Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet. 1996;5:1229-1235.
15. Kleinjan DA, Seawright A, Schedl A, et al. Aniridia-associated translocations, DNase hyper-sensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. Hum Mol Genet. 2001;10:2049-2059.
16. Lettice LA, Horikoshi T, Heaney SJ, et al. Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U SA. 2002;99:7548-7553.
17. Cook PR. Nongenic transcription, gene regulation and action at a distance. J Cell Sci. 2003;116: 4483-4491.
18. Ho Y, Elefant F, Liebhaber SA, Cooke NE. Locus control region transcription plays an active role in long-range gene activation. Mol Cell. 2006;23: 365-375.
19. Nobrega MA, Ovcharenko I,Afzal V, Rubin EM. Scanning human gene deserts for long-range enhancers. Science. 2003;302:413.
20. Pfeifer D, Kist R, Dewar K, et al. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region.Am J Hum Genet. 1999; 65:111-124.
21. Kioussis D, Vanin E, deLange T, Flavell RA, Grosveld FG. Beta-globin gene inactivation by DNA translocation in gamma beta-thalassaemia. Nature. 1983;306:662-666.
22. De GM, Viprakasit V, Hughes JR, et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science. 2006;312:1215-1217.